Prolonged release of bone morphogenetic protein-2 in vivo by gene transfection with DNA-functionalized calcium phosphate nanoparticle-loaded collagen scaffolds.

In the combination of scaffolds immersed in growth factor solutions， the release of growth factors mainly depends on scaffold degradation. However， the release of bone morphogenetic protein (BMP)-2 at an appropriate concentration during the stage of tissue regeneration would enhance bone regeneration. To achieve this condition， the present study was performed to investigate the effects of scaffolds combined with gene transfection using non-viral vectors. Nanohydroxyapatite-collagen (nHAC) scaffolds cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) or ascorbic acid/copper chloride， and a collagen scaffold (Terdermis®) were prepared， loaded with BMP-2-encoding plasmid DNA-functionalized calcium phosphate nanoparticles (CaP)， naked plasmid DNA， or BMP-2 solution， and implanted in rats. The yield of released BMP-2 and its releasing period， respectively， were larger and longer from the scaffolds loaded with CaP than from those incubated with BMP-2 solution. In addition， the alkaline phosphatase activity induced by the CaP-loaded scaffolds was higher. Histological analysis showed that released BMP-2 could be observed on the macrophages or multinuclear giant cells surrounding the nHAC fragments or collagen fibres. TRAP-positive or OCN-positive sites were observed in all groups and a mineralization area was observed in the Terdermis®/CaP sample. The present study demonstrates that gene transfection by scaffold loaded with CaP gene transfer vectors induces a larger yield of BMP-2 for a longer period than by scaffolds loaded with BMP-2 solution or naked plasmid.